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Abstract
Background: A simple method called RAPLOA, to rapidly assess what proportion of people in a community are
infected with L. loa and hence which communities are at high risk of severe adverse reactions following ivermectin
treatment, was developed in Cameroon and Nigeria. The method needed further validation in other geographical
and cultural contexts before its application in all endemic countries. The present study was designed to validate
RAPLOA in two regions in the North East and South West of the Democratic Republic of Congo.
Methods: In each study region, villages were selected from different bio-ecological zones in order to cover a wide
range of loiasis endemicity. In each selected community, 80 people above the age of 15 years were interviewed
for a history of eye worm (migration of adult L. loa under the conjunctiva of the eye) and parasitologically
examined for the presence and intensity of L. loa infection. In total, 8100 individuals from 99 villages were enrolled
into the study.
Results: The results confirmed the findings of the original RAPLOA study: i) the eye worm phenomenon was well-
known in all endemic areas, ii) there was a clear relationship between the prevalence of eye worm history and the
prevalence and intensity of L. loa microfilaraemia, and iii) using a threshold of 40%, the prevalence of eye worm
history was a sensitive and specific indicator of high-risk communities.
Conclusion: Following this successful validation, RAPLOA was recommended for the assessment of loiasis
endemicity in areas targeted for ivermectin treatment by lymphatic filariasis and onchocerciasis control
programmes.
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Background
The control of onchocerciasis in Africa is based on mass
treatment with ivermectin. Community-directed distri-
bution of annual doses of ivermectin, introduced by the
African Programme for Onchocerciasis Control (APOC),
is an important component of the control strategy. Each
community itself is in charge of designing and imple-
menting the ivermectin treatment [1]. This strategy has
been very successful and more than 65 million people in
onchocerciasis endemic areas are treated annually with
ivermectin [2,3].
However, several reports from Cameroon indicated
that high microfilaraemia of Loa loa m a yb ea s s o c i a t e d
with severe and sometimes fatal encephalopathic reac-
tions in patients who had taken ivermectin against
onchocerciasis [4-6]. The risk of severe adverse reactions
has been a major preoccupation for ivermectin treat-
ment programmes throughout the central African sub-
region where L. loa coexists with Onchocerca volvulus
[7]. Several treatment programmes have been inter-
rupted in Cameroon and the Democratic Republic of
Congo (DRC).
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treatment in L. loa infected individuals is related to the
intensity of loiasis infection: the risk of developing
marked or serious reactions is significantly higher when
the L. loa exceeds 8,000 microfilariae/ml. The severity
of adverse reaction becomes obvious in patients with
more than 30,000 microfilariae/ml and the risk is very
high for loads above 50,000 microfilariae/ml [5]. The
prevalence of high microfilarial loads is closely related
to the overall prevalence of microfilaraemia, and it has
been proposed that a microfilarial prevalence of 20% be
regarded as the threshold, above which there is an unac-
ceptable risk of severe adverse reactions [8]. It is critical,
therefore, that onchocerciasis control programmes iden-
tify such high-risk communities and withhold ivermectin
treatment or make special provisions to ensure that
severe adverse reactions are quickly detected and prop-
erly managed.
In the search for simple, non-invasive methods that
can facilitate the large scale identification of high risk
communities, a study carried out in Cameroon and
Nigeria in 2001, supported by the UNDP/World bank/
WHO Special Programme for Research and Training in
Tropical Diseases (TDR) and APOC, led to the develop-
ment of a Rapid Assessment Procedure for loiasis
(RAPLOA) [9,10]. This method is based on a striking
clinical manifestation of loiasis, the migration of the
adult Ll o aworm under the conjunctiva of the eye. The
major findings from the RAPLOA development study
were the following: (i) the eye worm phenomenon is
well known in L. loa endemic areas and people always
have local names for it; (ii) there was a clear relationship
between the percentage of community members that
reported a history of eye worm and the community pre-
valence of loiasis infection; (iii) using a threshold of
4 0 % ,t h ep r e v a l e n c eo fe y ew o r mh i s t o r yw a sag o o d
indicator of high-risk communities, i.e. communities
where the prevalence of L. loa microfilaraemia was
greater than 20%, the prevalence of high microfilarial
loads (> 8,000 mf/ml) was greater than 5%, or the preva-
lence of very high microfilarial loads (> 30,000 mf/ml)
was greater than 2%; (iv) the Rapid Assessment proce-
dure of loaisis (RAPLOA) based on the prevalence of
the history of eye worm had a high sensitivity and speci-
ficity for detecting high risk communities.
Based on these results, the independent expert com-
mittee of the African Programme for Onchocerciasis
Control (APOC) endorsed the operational use of
RAPLOA in Cameroon and Nigeria, but recommended
further validation in other geographical areas to find out
if those major findings are reproducible before the
method could be recommended for all loiasis endemic
countries. A validation study was therefore undertaken
in two sites located at some 2000 km from each other
in the South West and North East of the Democratic
Republic of Congo.
Following the completion of the validation study in
2004, the results were reported to the expert committees
of APOC and the Mectizan Donation Programme which
jointly recommended the use of RAPLOA to estimate
the prevalence of L. loa in all areas in Africa suspected
to be endemic for this parasite [11]. APOC subsequently
started a large-scale application of RAPLOA for map-
ping the distribution of loiasis endemicity in potentially
endemic countries in Africa. Much of this mapping has
now been completed and the results have begun to
appear in the scientific literature [12,13], including a
major publication with a comprehensive map of loiasis
in Africa based on RAPLOA surveys in 4,798 commu-
nities in 11 potentially endemic African countries [14].
However, now that these mapping results are becoming
widely available for operational decision-making for
onchocerciasis control and lymphatic filariasis elimina-
tion programs in Africa, the question of the validity of
the RAPLOA method is increasingly raised. It therefore
became important to publish the results of the valida-
tion study in the scientific literature and provide the
scientific community with the complete evidence on the
validity of the RAPLOA method for estimating the pre-
valence of loiasis in different African countries. This
article therefore provides a comprehensive report of the
methodology and results of the validation study in two
sites in the Democratic Republic of Congo.
Methods
Study design
The study was designed to study the relationship
between the prevalence of eye worm history and parasi-
tological indicators of loiasis infection, and to compare
the results with the main findings of the earlier
RAPLOA development study. The same methodology as
in the previous study was applied, in which communities
were selected from a wide range of loiasis endemicity
levels. In each selected village 80 randomly selected peo-
ple were interviewed using the standard RAPLOA meth-
odology and a blood sample was examined for L. loa
microfilariae.
The surveys were done between January and May
2004 by research teams made up of parasitologists,
social scientists and epidemiologists. Each team was
trained on the study methodology, the field data collec-
tion involving both parasitologic and social science
methods, the microscopic processing of the thick blood
smears and data management.
Study sites
The study was carried out in two sites of the Demo-
cratic Republic of Congo; the Bas-Congo and the
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lages were selected from three different bio-ecological
zones (forest, mosaic forest savannah and savannah),
ranging from potentially high to potentially low endemi-
city levels for loiasis. The forest areas were Pawa and
Wamba in the North East and Bas-fleuve (Mayombe) in
the South West regions; 15 communities were to be sur-
veyed in each of the forest areas. The savannah area
involved Aru and Aba in the North East and Lukaya in
the South West; 15 communities were to be surveyed in
each of the savannah areas. The transition forest/savan-
nah areas were made up of degraded forest with patches
of gallery forests surrounded with vast savannah areas
and involved Watsa in the North East and Cataracte in
the South West; 20 communities were to be surveyed in
each of the forest/savannah areas. Surveys were com-
pleted in all but one of the intended villages, giving data
from a total of 99 villages for analysis.
Study population
The study population consisted of males and females aged
15 years and above, who had been resident in the village
for a minimum of five consecutive years and who had not
taken antifilarial treatment within the year. Using a stan-
dard informed consent procedure, each selected individual
was informed about the purpose of the study, the methods
used, the voluntarily nature of participation and that they
were free to refuse to participate. Every individual who
consented to participate in the study signed an individual
informed consent form and was given an identity code,
Figure 1 Location of the validation villages in the Democratic Republic of Congo.
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gically for L. loa. The investigation was carried out accord-
ing to a research protocol approved by the Democratic
Republic of Congo Ministry of Public Health and the Ethi-
cal Review Committee of the World Health Organisation.
Rapid Assessment Procedure for Loiasis (RAPLOA)
The Rapid Assessment Procedure was based on the
restricted definition of eye worm; i.e. the past experience
of eye worm, confirmed by a photograph of an adult
worm of L. loa in the white part of the eye and with the
duration of the most recent episode being between 1
and 7 days [9,10]
Questionnaires were administered in the French lan-
guage or in local languages (Lingala, Kikongo and
Kiyombe for the South West, Swahili, Kibudu and Ban-
gala for the North East study site). The interview process
took place according to the RAPLOA guidelines [15].
A community questionnaire was used to brief key
informants, including village heads, school teachers,
health workers, patent medicine dealers and traditional
healers, on the objectives and expected outcomes of the
study and elicit the local names for eye worm.
For the individual questionnaire, all consenting eligible
individuals in the household were questioned on their
past experience of eye worm. If the answer was positive,
the individual was shown a photograph of the eye worm
and guided to identify the worm on the picture, fol-
lowed by another question on the duration of the most
recent episode. The photograph was the same photo-
graph used in the development of RAPLOA. Individuals
who reported to have experienced eye worm, who could
recognise the worm on the photograph and who
reported the duration of the last episode to be between
1-7 days were classified as RAPLOA positive and the
rest were RAPLOA negative.
Parasitological examination
Thick blood films to search for L. Loa microfilariae were
prepared from a standardised 50 μl finger-prick blood
sample, collected under aseptic conditions between 10:00
and 16:00 hours using a 75 μl non-heparinised capillary
tube. The smear was prepared by spreading the blood on a
clean slide over an area of 1.5 cm × 2.5 cm. Blood smears
were de-haemoglobinised with tap water for 5 to 10 min-
utes, fixed with methanol for 1 minute and stained in 10%
Giemsa for 45 minutes. The slides were read under a
microscope at × 10. The microfilariae of L. loa were iden-
tified [16] and counted individually. The counts were
expressed as microfilariae per milliliter (mf/ml) of blood.
Data analysis
Data from the two study sites and from the earlier
development study were analyzed using R Version
2.10.1 [17]. For each community the Rapid Assessment
Procedures index was calculated as the proportion of
people who reported past experience of eye worm, con-
firmed by means of a photograph of adult L. loa in the
eye and that it lasted 1-7 days. Three parasitological
indices were also calculated: prevalence of microfilarae-
mia in thick blood film; prevalence of high intensity of
infection (> 8000 microfilariae/ml); prevalence of very
high intensity of infection (> 30000 microfilariae/ml).
Each index was analysed on the logit-scale to linearise
the relationships amongst the four indices.
Linear regressions, weighted by the sample size in
each community, were fitted to the relationship between
the logit-transformed RAPLOA index and each of the
parasitological indices. In each case, the single regres-
sion line for the complete validation data-set was com-
pared with the two regression lines for the separate sites
using a likelihood ratio test (F-test). The same method
was then used to compare regression lines fitted to the
complete validation data-setf r o mD e m o c r a t i cR e p u b l i c
of Congo and the RAPLOA development data-set from
Cameroon and Nigeria.
To assess the performance of a RAPLOA-based index
against Mf prevalence thresholds to detect high risk
communities, we defined the calibration points between
the RAPLOA index and each of the parasitological
indices by inspection of scatterplots. We then calculated
the sensitivity and specificity of the RAPLOA index for
detecting high risk communities, firstly by an in-sample
method using the data from the two validation sites in
DRC, then by an out-of-sample method using the data
from the development study in Cameroon. The out-of-
sample performance was also investigated using ROC
curves over a wide range of calibration points, and the
empirical optimum calculated as the value that mini-
mized the distance between the ROC curve and the
point (0,1), that represents perfect sensitivity and
specificity.
Results
Table 1 summarises the number of communities sur-
veyed and numbers of people examined during the
study. In all, 8100 individuals were examined from 99
communities, of which 49 were in South West DRC and
50 in North East DRC.
Knowledge of eye worm, attitude and practice in study
communities
Local terms for eye worms were reported from both
study sites; most were descriptive. Within the Kikongo
language group of South West DRC, the local term was
“n y a k as am e s o ” = worm of the eye. In Swahili and
Kibula in North East DRC it was “upiyo” = caterpillar of
the eye. In the forest areas in all the study sites, some
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able of removing adult L. loa as they migrate across the
sub-conjunctiva. More often, villagers used plant
extracts to accelerate the migration of the worm across
the eye.
Level of endemicity of L. loa in different bio-ecological
zones
The prevalence of L. loa infection varied considerably
between bio-ecological zones within each study site. All
of the forest zones were highly endemic for loiasis. In
South West DRC, the prevalence of microfilaraemia in
the forest villages had a range of 17.0-38.2, with a med-
ian of 23.3. In North East DRC, the microfilaraemia pre-
valence range was 8.8 to 38.5, with a median of 28.8.
Transition forest savannah zones recorded a wide range
of microfilaraemia prevalence between study sites.
Savannah zones also recorded heterogeneity in preva-
lence, both in South West DRC [range 0-30.2, Median
13.6] and in North East DRC [range 0-2.5, Median 3.6].
The prevalences of high (> 8000 microfilariae/ml) and
of very high (> 30,000 microfilariae/ml) intensity follow
the pattern of the prevalence of L. loa microfilariae in
different bio-ecological zones. In the forest areas, more
than 7% of people examined harboured more than 8000
mf/ml and more than 2% of people examined harboured
more than 30,000 microfilariae/ml in their blood. In the
transition forest/savannah and in the savannah zones,
the prevalences of high intensity and very high intensity
of infection were in general lower.
RAPLOA prevalence was higher in the forest bio-eco-
logical zones of both study sites: 59.6% in the South
West DRC and 63.9% in the North East DRC. By com-
parison with the forest areas, RAPLOA prevalence was
in general lower in the savannah and transition forest/
savannah areas.
Relationship between the prevalence and intensity of L.
loa infection
Figure 2 shows the relationship between the prevalence
and intensity of L. loa infection at the community level
from the validation study along with the original data
from Cameroon and Nigeria. The F-test for the differ-
ence between the fitted regression relationships in the
two validation sites is not significant (p > 0.9). The F-
test comparing the pooled data from the two validation
sites and the original data from Cameroon and Nigeria
is significant (p = 0.002), but the difference between the
two is small, as shown by the two calibration curves in
Figure 2. The prevalence of high intensity of L. loa
infection (> 8000 microfilariae/ml) increased with the
prevalence of L. loa microfilaraemia. The validation data
confirmed previous findings that the 20% threshold pre-
valence of L. loa in thick smears at the community level
corresponds to 5% and above of high intensity of
infection.
Relationship between RAPLOA prevalence and L. loa
microfilaraemia
Figure 3 shows the relationship between the prevalence of
eye worm (RAPLOA) and the prevalence of L. loa microfi-
laraemia. Once more, the F-test for the difference between
the fitted regression relationships in the two validation
sites is not significant (p = 0.594) whereas the difference
Table 1 Study population with prevalence RAPLOA, microfilaraemia, high microfilaraemia (> 8000 Mf/ml), very high
microfilaraemia (30,000 Mf/ml) in different bio-ecological zones of the two validation study sites.
Study
sites
Bio-
ecological
zones
Number of
communities
Number of
individuals
examined
RAPLOA
prevalence
(%)
Prevalence
microfilaraemia
(%)
Prevalence
microfilaraemia >
8000 mf/ml
(%)
Prevalence
microfilaraemia >
30,000 mf/ml
(%)
South
West
DRC
Forest 14 1130 59.6 24.6 7.6 2.3
Transition
forest/
savannah
20 1686 16.0 2.6 0.3 0
Savannah 15 1193 27.5 14 4.1 0.6
Subtotal 49 4009 31.7 12.2 3.5 0.8
North
East DRC
Forest 15 1225 63.9 27.3 7.8 2.3
Transition
forest/
savannah
20 1249 2.1 0.4 0 0
Savannah 15 1617 17.9 4.0 1.1 0.3
Subtotal 50 4091 26.9 9.9 2.7 0.8
Total 99 8100 29.3 11.0 3.1 0.8
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the original data from Cameroon and Nigeria is significant
(p < 0.001) but small in magnitude. A cut-off point of 40%
prevalence of eye worm corresponds approximately to
20% prevalence of microfilaraemia in the validation study
sites. We also used this same cut-off point to correspond
to 5% prevalence of high intensity microfilaraemia (Figure
4) and to 2% prevalence of very high intensity microfilar-
aemia (Figure 5). In the case of very high intensity microfi-
laraemia, the linear regression model does not fit the data
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Figure 3 Relationship between the prevalence of microfilaraemia and the prevalence of the history of eye worm (RAPLOA) (original
and validation data). The black and red lines show the calibration models fitted to the original and validation data, respectively. The left-hand
panel shows the data and models on the log-odds scale, the right-hand panel on the prevalence scale. The original data are from [10]).
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as a prognostic tool.
Sensitivity and specificity of RAPLOA with a threshold of
40%
Table 2 shows the in-sample and out-of-sample sensitiv-
ities and specificities of the 40% cut-off value of the
RAPLOA index as a proxy for all three of the parasitolo-
gical thresholds: 20% positive Mf, 5% Mf > 8 K and 2%
Mf > 30 K. Figure 6 shows the three corresponding out-
of-sample ROC curves. The 40% RAPLOA cut-off is
robust: all three out-of-sample sensitivities are greater
than 90% and all three out-of-sample specificities are
greater than 76%; the areas under the curves are 0.889,
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Figure 4 Relationship between the prevalence of high intensity of microfilaraemia (> 8000 Mf/ml) and the prevalence of the history
of eye worm (RAPLOA) (original and validation data). The solid line shows the regression model fitted to the validation data. The original
data are from [10]).
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Figure 5 Relationship between the prevalence of very high intensity of microfilaraemia (> 30,000 Mf/ml) and the prevalence of the
history of eye worm (RAPLOA): (original and validation data). The solid line shows the regression model fitted to the validation data. The
original data are from [10]).
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Page 7 of 100.880 and 0.832 and in all three cases, the point closest
to (0,1) corresponds to a RAPLOA prevalence of 39%.
Discussion
RAPLOA is a rapid assessment method of the preva-
lence of loiasis at the community level that was devel-
oped during a study in Cameroon and Nigeria [9,10].
Based on the results of this initial study, the indepen-
dent expert committee of the African Programme for
Onchocerciasis Control (APOC) endorsed the opera-
tional use of RAPLOA in Cameroon and Nigeria, but
recommended further validation in other geographic
areas and different socio-cultural contexts before the
method could be applied in all endemic countries. The
studies were therefore expanded to two study sites in
t h eD e m o c r a t i cR e p u b l i co ft h eC o n g o ,w h i c hc a r r i e s
one-third of the global burden of onchocerciasis.
The two validation sites are located at a distance of
some 2000 km from each other, in the Orientale Pro-
vince in the North East of the Democratic Republic of
Congo and in the Bas-Congo Province in the West of
the country. The site in Orientale Province is near the
eastern limits of the overall zone in Africa where loiasis
may be endemic, while the site in Bas-Congo Province
is in the South West of the loiasis zone [7,14]. Together
with the original study sites in Cameroon and Nigeria,
located in the North West of the loiasis zone, the
RAPLOA sites provide a fair representation of the prin-
cipal areas in Africa where loiasis is endemic.
Each of the two validation sites also covers a wide
range of loiasis endemicity levels. The highest levels of
endemicity were observed in the forest zones of the two
study sites which could be explained by the abundant
presence of Chrysops vectors which have numerous
breeding sites in such forest regions [18-21]. The level
of endemicity was much lower in the transition forest/
savannah and savannah bio-ecological zones. Neverthe-
less, in several locations in the savannah and transition
zones, relatively high endemicity of loiasis was recorded.
This was seen in the South West DRC, not far from the
Table 2 Sensitivity and specificity of RAPLOA with threshold of 40% (validation versus original data)
Source of Data Indicator of high risk of severe Adverse reactions Sensitivity Specificity
Validation study in DRC Prevalence of L. loa Mf > 20% 100.0 90.1
Prevalence of L. loa 8,000+ Mf > 5% 96.3 87.5
Prevalence of L. loa 30,000+ Mf > 2% 95.0 79.7
Original study in Cameroon and Prevalence of L. loa Mf > 20% 100.0 92.4
Nigeria [8] Prevalence of L. loa 8,000+ Mf > 5% 100.0 91.0
Prevalence of L. loa 30,000+ Mf > 2% 100.0 79.2
0.0 0.2 0.4 0.6 0.8
0
.
0
0
.
2
0
.
4
0
.
6
0
.
8
1
.
0
P(Mf+)=0.2
1−specificity
s
e
n
s
i
t
i
v
i
t
y
0 . 00 . 20 . 40 . 60 . 8
0
.
0
0
.
2
0
.
4
0
.
6
0
.
8
1
.
0
P(Mf>8K)=0.05
1−specificity
s
e
n
s
i
t
i
v
i
t
y
0.0 0.2 0.4 0.6 0.8
0
.
0
0
.
2
0
.
4
0
.
6
0
.
8
1
.
0
P(Mf>30K)=0.02
1−specificity
s
e
n
s
i
t
i
v
i
t
y
Figure 6 ROC curves for the sensitivity and specificity of the RAPLOA index as a proxy for parasitological thresholds 20% positive Mf
(left-hand panel), 5% Mf > 8 K (centre panel) and 2% Mf > 30 K (right-hand panel). The arrow on each ROC curve identifies the point
closest to (0,1).
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Page 8 of 10city of Kinshasa, and in the North East DRC (Uelés
region). The presence of loiasis in the savannah and
transition zones is a result of hillside forests and gallery
forests along the important rivers [22].
One of the outstanding questions after the develop-
ment of RAPLOA was to know how far this method
could remain useful in the prediction of the endemicity
of loiasis in socio-cultural contexts different from those
in which it was developed. The RAPLOA method is
based on the history of clinical manifestations and lar-
gely depends on the appreciation of the eye worm phe-
nomenon by the members of a community. The results
of our validation study confirmed previous observations
that the experience of eye worm migration is well
known by members of endemic communities irrespec-
tive of their cultures and dialects [10,23,24] and that
they have descriptive local names for the phenomenon.
The subconjunctival migration of adult L. loa is a spec-
tacular phenomenon in endemic communities, which
are often located far from any health facility. This situa-
tion has even produced local “eye worm specialists” who
are able to remove the migrating worms from the eye
using a special tree spine, or a plant extract to accelerate
the disappearance of worms from the sub-conjunctiva
tissue.
The RAPLOA tool consists of just three very simple
questions, including “have you ever had the condition
s h o w ni nt h i sp i c t u r e ? ” asked while showing a clear
photograph of a worm moving across the white part of
an eye. Based on the response to these three questions
b yas a m p l eo fa d u l t s ,t h ep r e v a l e n c eo ft h eh i s t o r yo f
eye worm, or RAPLOA prevalence, is calculated for
each community as an indicator of the level of loiasis
endemicity. The study has confirmed that there exists a
close relationship between the RAPLOA prevalence and
parasitological indicators of loiasis endemicity at the
community level, and that the RAPLOA prevalence can
be used to identify communities where there is a high
risk for adverse reactions to ivermectin treatment, i.e.
communities where the prevalence of microfilaraemia is
greater than 20%, the prevalence of high intensity (8,000
mf/ml) of L. loa infection is greater than 5%, or the pre-
valence of very high (30,000 mf/ml) infection is greater
than 2%. The optimal diagnostic threshold for RAPLOA
prevalence was 39% in the validation study, a result that
is nearly identical to the 40% obtained in the original
study. The sensitivity and specificity of a RAPLOA pre-
valence of 40% for the diagnosis of high-risk commu-
nities were high, with the sensitivity ranging from 95%
to 100% and the specificity from 80% to 90%, and these
figures are very similar to the sensitivity and specificity
estimates obtained in the original study.
Conclusion
The results of the validation study in the two sites in the
Democratic Republic of Congo confirm the main find-
ings of the original study in Cameroon and Nigeria, and
the study has therefore validated the RAPLOA method
for the rapid assessment of the prevalence of loiasis.
The method is shown to produce consistent results in
different geographic and social cultural settings, and to
work as well as the much more cumbersome and inva-
sive finger-prick thick blood film parasitological method.
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